Contract 75H71024F80345
Mckesson Corporation · Department Of Health And Human Services · August 29, 2024
Mckesson Corporation was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on August 29, 2024 for $13.45 million (current value) of work in pharmaceutical preparation manufacturing. Performance is in Chinle, AZ. This is a task or delivery order issued under parent IDIQ 36W79720D0001. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 25, 2026. If all options are exercised, the contract could reach $13.45 million.
Contract details
- PIID
- 75H71024F80345
- Parent IDIQ
- 36W79720D0001
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Chinle, AZ
- First action
- August 29, 2024
- Latest action
- March 25, 2026
Description
DEOB AND CLOSEOUT
Modification timeline
-
March 25, 2026Mod P00008 · Funding Only Action$13.45M
-
August 7, 2025Mod P00007 · Supplemental Agreement For Work Within ScopePHARMACEUTICAL AND MEDICAL/SURGICAL PRODUCTS TO BE ORDERED ON AN AS NEEDED BASIS$19.30M
-
August 29, 2024Base awardPHARMACEUTICAL AND MEDICAL/SURGICAL PRODUCTS TO BE ORDERED ON AN AS NEEDED BASIS$1.00M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Genentech USA, Inc | Department Of Health And Human Services | March 27, 2026 | $45.11M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71024F80345?
Contract 75H71024F80345 is a federal contract awarded to Mckesson Corporation by Department Of Health And Human Services on August 29, 2024 for $13.45 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75H71024F80345?
Mckesson Corporation won contract 75H71024F80345 from Department Of Health And Human Services.
How much is contract 75H71024F80345 worth?
Contract 75H71024F80345 has obligated $0 to date but carries a potential ceiling of $13.45 million if fully funded and all options are exercised.